These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38910023)
41. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation. Lee OH; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jang Y Am J Cardiol; 2018 Jun; 121(12):1534-1539. PubMed ID: 29631803 [TBL] [Abstract][Full Text] [Related]
42. Percutaneous Left Atrial Appendage Closure: Current Devices and Clinical Outcomes. Asmarats L; Rodés-Cabau J Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146668 [TBL] [Abstract][Full Text] [Related]
43. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention. Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355 [TBL] [Abstract][Full Text] [Related]
44. Percutaneous closure of the left atrial appendage for thromboembolic prevention in atrial fibrillation. Faustino A; Paiva L; Providência R; Cação R; Costa M; Leitão-Marques A Rev Port Cardiol; 2013 Apr; 32(4):311-23. PubMed ID: 23528437 [TBL] [Abstract][Full Text] [Related]
45. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management. Jackson LR; Jackson KP; Thomas KL Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665 [TBL] [Abstract][Full Text] [Related]
46. Left Atrial Appendage Occlusion/Exclusion: Procedural Image Guidance with Transesophageal Echocardiography. Vainrib AF; Harb SC; Jaber W; Benenstein RJ; Aizer A; Chinitz LA; Saric M J Am Soc Echocardiogr; 2018 Apr; 31(4):454-474. PubMed ID: 29158017 [TBL] [Abstract][Full Text] [Related]
47. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. Bayard YL; Omran H; Neuzil P; Thuesen L; Pichler M; Rowland E; Ramondo A; Ruzyllo W; Budts W; Montalescot G; Brugada P; Serruys PW; Vahanian A; Piéchaud JF; Bartorelli A; Marco J; Probst P; Kuck KH; Ostermayer SH; Büscheck F; Fischer E; Leetz M; Sievert H EuroIntervention; 2010 Jun; 6(2):220-6. PubMed ID: 20562072 [TBL] [Abstract][Full Text] [Related]
48. Left atrial appendage closure with amplatzer septal occluder in patients with atrial fibrillation: CT-based morphologic considerations. Vaitkus PT; Wang DD; Guerrero M; Greenbaum A; O'Neill W J Invasive Cardiol; 2015 May; 27(5):258-62. PubMed ID: 25929303 [TBL] [Abstract][Full Text] [Related]
49. Effectiveness and safety of transcatheter left atrial appendage closure. Nakajima Y J Cardiol; 2022 Feb; 79(2):186-193. PubMed ID: 34565689 [TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years. Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099 [TBL] [Abstract][Full Text] [Related]
51. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis. Tsai YC; Phan K; Munkholm-Larsen S; Tian DH; La Meir M; Yan TD Eur J Cardiothorac Surg; 2015 May; 47(5):847-54. PubMed ID: 25064051 [TBL] [Abstract][Full Text] [Related]
52. Lifetech LAmbre: a new promising and novel device in the interventional stroke prevention. Schnupp S; Ajmi I; Brachmann J; Mahnkopf C Future Cardiol; 2019 Nov; 15(6):405-410. PubMed ID: 31710249 [TBL] [Abstract][Full Text] [Related]
56. [Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences]. Fontos G; Andréka P; Temesvári A; Wéber D; Szatmári A Orv Hetil; 2010 May; 151(18):725-34. PubMed ID: 20409999 [TBL] [Abstract][Full Text] [Related]
57. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Bajwa RJ; Kovell L; Resar JR; Arbab-Zadeh A; Mandal K; Calkins H; Berger RD Clin Cardiol; 2017 Oct; 40(10):825-831. PubMed ID: 28750152 [TBL] [Abstract][Full Text] [Related]
58. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. Lewalter T; Kanagaratnam P; Schmidt B; Rosenqvist M; Nielsen-Kudsk JE; Ibrahim R; Albers BA; Camm AJ Europace; 2014 May; 16(5):626-30. PubMed ID: 24798956 [TBL] [Abstract][Full Text] [Related]
59. The WATCHMAN left atrial appendage closure device for atrial fibrillation. Möbius-Winkler S; Sandri M; Mangner N; Lurz P; Dähnert I; Schuler G J Vis Exp; 2012 Feb; (60):. PubMed ID: 22395336 [TBL] [Abstract][Full Text] [Related]
60. Where We Stand on Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. Safavi-Naeini P; Rasekh A Tex Heart Inst J; 2016 Aug; 43(4):320-3. PubMed ID: 27547142 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]